Spinal Fusion Stimulator
PMA P850035
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP850035 | Date30 Apr 1987 | StatusActive |
Recalls
-
- Terminated Z-0287-2019
Lack of adequate validation and controls to ensure that product cleanliness parameters were consistently met.
-
- Terminated Z-2119-2017
- Terminated Z-2118-2017
Zimmer Biomet is conducting a medical device field action for the SpF PLUS-Mini and SpF XL IIB Implantable Spinal Fusion Stimulator products due to higher than allowed cytotoxicity levels found during routine process monitoring with the product.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Full name
- Spf Spinal Fusion Stimulator
- Trade Name
- SpF® Implantable Spinal Fusion Stimulator
- Generic Name
- Stimulator, invasive bone growth
- PMA Number
- FDA Product Code
- LOE
- Device Class
- Class III
- Advisory Committee
- Orthopedic
- FDA Decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Spinal Fusion Stimulator is an invasive bone growth stimulator designed to promote spinal fusion. Classified as a Class III device under FDA regulations, it is intended for implantation to electrically stimulate bone growth in spinal fusion procedures, aiding in the consolidation of vertebrae.
This device is supplied sterile and intended for single-use implantation by a surgeon in an operating room setting. It is regulated under an FDA Premarket Approval (PMA) with PMA number P850035 and falls under the product code LOE. Proper storage requires adherence to sterile packaging instructions until use.